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Abstract
Maternal cigarette smoking has adverse effects on pregnancy outcomes. The granulocyte-macrophage colony-stimulating
factor (GM-CSF) is an essential cytokine for a normal pregnancy. We investigated the impact of cigarette smoke extract (CSE)
on GM-CSF expression in human cytotrophoblast cells and suggested a cellular mechanism underlying the CSE-induced
GM-CSF expression. An immortalized normal human trophoblast cell line (B6Tert-1) was treated with CSE. The viability and
proliferation of the CSE-treated B6Tert-1 cells were evaluated, and the expression of GM-CSF in these cells was quantified at
the mRNA and the protein levels by means of reverse-transcription and quantitative polymerase chain reaction (RT-qPCR);
and enzyme-linked immunosorbent assay (ELISA), respectively. Human trophoblast cells treated with CSE had an increased
expression of GM-CSF at both the mRNA and the protein levels. The CSE-induced GM-CSF expression was synergistically
enhanced by the addition of the proteasome inhibitor MG-132, but inhibited by AG-1478, an inhibitor of the epidermal
growth factor receptor (EGFR) kinase. Furthermore, CSE treatment increased the phosphorylation of the extracellular-signal
regulated kinases (ERK1/2) in the trophoblast cells. The expression of other growth factors such as heparin-binding
epidermal growth factor-like growth factor (HB-EGF) and vascular endothelial growth factor (VEGF) was also evaluated. Our
data suggested that cigarette smoking and proteasome inhibition synergistically up-regulate GM-CSF cytokine expression
by activating the EGFR signaling pathway.
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Introduction
Maternal cigarette smoking has negative impacts on all aspects
of human reproduction, causing impaired fertility, increased risk of
pregnancy complications and poor pregnancy outcomes such as
fetal growth restriction, premature delivery, fetal and infant death,
and developmental problems with the newborn [1–5]. Paradox-
ically, maternal cigarette smoking is also associated with a reduced
risk of preeclampsia by up to 50% with a dose-response pattern
[6–9]. Smokers with preeclampsia, however, have very high risks
of even worse outcomes than nonsmokers [10]. Preeclampsia
affects about 5–10% of all pregnancies and is a leading cause of
maternal and fetal/neonatal morbidity and mortality worldwide
[11]. Smoking may have effects on angiogenesis of placenta
arteries, endothelial function and the immune system, but the
underlying mechanisms are not fully understood.
The granulocyte-macrophage colony-stimulating factor (GM-
CSF) is a hematopoietic cytokine which plays an important role in
the proliferation, differentiation and function of myeloid cells [12],
and is an important regulator of the host defense and response to
external insult and injury [13]. Other studies suggested that GM-
CSF also plays a key role in embryo development by regulating the
cell number and viability of mouse and human blastocysts [14].
Aberrant GM-CSF expression will have impacts on embryo
implantation as well as on fetal and placental development. Mice
lacking the GM-CSF gene had impaired fertility, fetal growth
retardation, and fetal loss in late gestation [15,16]. Administration
of GM-CSF exogenously could protect against embryo loss and
enhance fetal growth [17–19].
Throughout pregnancy, a high level of GM-CSF expression can
be observed at the feto-maternal interface, as well as in the
invading cytotrophoblast cells [20]. GM-CSF could provide the
necessary signals for trophoblast differentiation and function. The
levels of GM-CSF in the peripheral blood of women with normal
pregnancy or preeclampsia have been evaluated, but the results
were controversial. Hayashi and colleagues [21] reported that the
level of GM-CSF is significantly higher in the peripheral blood and
the placenta of preeclamptic women than in the specimens of
women with normal pregnancy. In other reports, however, no
significant differences were found in the plasma levels of GM-CSF
between preeclamptic women and those with normal pregnancy
[22–25].
The regulation of GM-CSF expression in human trophoblast
cells under the influence of cigarette smoking has not been well
studied. The aim of this study was to investigate the effect of
cigarette smoke extract (CSE) on GM-CSF expression in normal
human trophoblast cells. We used an immortalized human normal
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cytotrophoblast cell line to investigate GM-CSF expression in the
absence or presence of CSE in the culture medium. We
demonstrated that proteasome inhibition leads to a significant
enhancement of CSE-induced GM-CSF expression via the EGFR
signaling pathway. The up-regulated expression of GM-CSF in the
trophoblasts after CSE exposure could play an important role in
maintaining trophoblast integrity to increase the chance of
survival.
Results
Effects of cigarette smoke extract (CSE) on B6Tert-1
trophoblast cell viability and proliferation
The viability of the B6Tert-1 cells was increased by as much as
50% when cultured in medium containing 1% to 10% CSE
(Figure 1A, p,0.05). The proliferation rate was increased by up to
29% when CSE at 1% to 5% was present in the medium
(Figure 1B, p,0.05). As a result of the toxic effect of CSE at the
higher concentrations (.20%) in the culture medium, the B6Tert-
1 cells had a reduced proliferation rate, at 70% of that of the
untreated cells; and a very low viability, at 20% to 40% of that of
the untreated cells. CSE at a final concentration of 10% slightly
increased B6Tert-1 cells’ proliferation rate, by 10%, but not
reaching statistical significance (p.0.05) compared to that of the
untreated cells; while the 10% CSE in the medium increased the
cell viability, by 43% (p,0.05). In the following experiments, a
final CSE concentration of 10% was used to ensure that the
viability and proliferation of the cells were not compromised by
the presence of CSE.
GM-CSF expression in B6Tert-1 cells under CSE exposure
CSE in the culture medium at a final concentration of 10%
increased the GM-CSF expression in the B6Tert-1 cells at the
mRNA level as measured by reverse-transcription and quantitative
polymerase chain reaction (RT-qPCR) (Figure 2A). The GM-CSF
mRNA expression increase was accompanied by an increased
secretion of the GM-CSF protein in the culture medium
(Figure 2B). We observed an up-regulation of GM-CSF mRNA
expression to 5.7-fold, while the secretion of GM-CSF protein in
the conditioned medium was increased to 4.3-fold.
Proteasome inhibition and cellular distribution of NF-kB
p65 subunit in B6Tert-1 cells under CSE exposure
Previous studies have shown that NF-kB is a key transcriptional
regulator of GM-CSF gene expression [26]. We investigated if this
pathway might be involved in the CSE-induced GM-CSF
transcription up-regulation. The B6Tert-1 cells were pre-treated
with the proteasome inhibitor MG-132 at 5 mM for 30 min before
exposure to 10% CSE for another 5 h. Due to the deleterious
consequences of long-term proteasome inhibition by MG-132 on
B6Tert-1 cell viability (data not shown), we treated the B6Tert-1
cells for 5 h with CSE in the presence of MG-132 for the
evaluation of GM-CSF mRNA expression changes. Proteasome
inhibition is expected to inactivate the NF-kB pathway by
reducing the degradation of the IkB inhibitor molecules, thus
preventing the translocation of the NF-kB transcription factor
from the cytosol to the nucleus and preventing GM-CSF
expression up-regulation. Unexpectedly, in the presence of the
proteasome inhibitor, the CSE-induced GM-CSF expression was
further up-regulated to ,10-fold as compared to the GM-CSF
expression level in cells treated with 10% CSE alone (Figure 3A).
Of note, the cells treated with 10% CSE for 5 h (Figure 3A) had a
less amount of GM-CSF mRNA as compared with those treated
for 2 days (Figure 2A). In a western blot analysis, we observed an
increased quantity of phosphorylated ERK1/2 (pERK1/2,
Figure 3B, lanes 2 & 3), a signaling molecule downstream of
EGFR in the CSE-treated or the CSE/MG-132-treated B6Tert-1
cells. The increase of pERK1/2 by the CSE/MG-132 treatment
was blocked by the addition of AG-1478 (Figure 3B, lane 4). The
addition of only MG-132 to the B6Tert-1 cells did not increase the
expression of GM-CSF mRNA (Figure 3A), but increased ERK1/
2 phosphorylation (Figure 3B, lane 5).
We further examined whether the transcription factor NF-kB
was translocated into the nucleus after the CSE treatment by
means of cellular immuno-fluorescent staining (Figure 3C) and
nuclear protein western blotting (Figure 3D). As shown in
Figure 3C, there was no apparent difference in the distribution
of the NF-kB p65 subunit shown by the punctate staining
surrounding the dark nuclear region (‘‘N’’) when cells were treated
with the following agents: no-treatment (a), CSE alone (b), CSE/
MG-132 (c), and MG-132 alone (d). TNF-a (tumor necrosis factor-
alpha) was used as a control cytokine to show the translocation of
NF-kB p65 subunit from the cytosol to the nucleus with the intense
Figure 1. Viability and proliferation assays. B6Tert-1 cells (16104)
were seeded in a 96-well plate in triplicates and grown overnight.
Cigarette smoke extract (CSE) was added in FD medium at different final
concentrations as indicated, and the cells were incubated for another
24 h. The viability and proliferation rate were monitored as described in
Materials and Methods. The data are expressed as the percentage of
CSE-treated/untreated, and represent the mean6 SEM. The experiment
was repeated for three times.
doi:10.1371/journal.pone.0043042.g001
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nuclear staining (e), indicating activation of the NF-kB pathway in
the B6Tert-1 cells in response to a known NF-kB-activating
cytokine [27]. The TNF-a-induced NF-kB translocation could be
blocked by the addition of MG-132 (f). By means of western blot
analysis, we showed that the majority of the NF-kB p65 subunit
was detected in the cytoplasm in the B6Tert-1 cells treated with
CSE, MG-132, or both (Figure 3D). Again, there was no apparent
difference in the distribution of the NF-kB p65 subunit in the
nucleus before and after the CSE treatment without or with
proteasome inhibition. GAPDH and nucleoporin p62 were used as
loading and fractionation controls in these western blot analyses.
We also performed CSE treatment on the B6Tert-1 cells for 1 h,
3 h and 5 h (data not shown), the results of NF-kB immunostain-
ing and western blotting were similar to those obtained from the
cells treated for 30 min (shown in Figure 3C and 3D). These
results indicated that the GM-CSF gene expression regulation by
CSE in the trophoblast cells may involve a proteasome inhibition
dependent but NF-kB independent mechanism.
Up-regulation of GM-CSF expression in B6Tert-1 cells by
CSE involves EGF/EGFR signaling
Next, we investigated if EGFR activation affected GM-CSF
expression. We showed in Figure 3A that the EGFR kinase
inhibitor AG-1478 blocked the CSE/MG-132-induced up-regu-
lation of GM-CSF expression. Furthermore, an inhibitor of
MEK1/2 (U0126) can also block the GM-CSF expression up-
regulation induced by CSE/MG-132. The involvement of EGF/
EGFR signaling pathway in the up-regulation of GM-CSF
expression was further supported by the results of treating the
B6Tert-1 cells with EGF (Figure 4). The addition of EGF to the
culture medium (FD) increased GM-CSF mRNA expression to
5.7-fold in 5 h of treatment. AG-1478 alone did not affect the
GM-CSF mRNA expression, but blocked the induction of GM-
CSF mRNA expression under EGF treatment.
GM-CSF or EGF increases the viability and proliferation of
B6Tert-1 cells
The responses of the B6Tert-1 trophoblast cells to GM-CSF or
EGF, manifested as changes in cell viability and proliferation were
shown in Figure 5. Cell viability and proliferation of the B6Tert-1
trophoblast cells were both increased in a dose-dependent manner
(p,0.05) when GM-CSF or EGF was added to the culture
medium. The cell viability was increased by up to 50% or 36% by
GM-CSF (100 ng/ml) or EGF (100 ng/ml), respectively, while the
proliferation rate was increased by up to 46% or 45%,
respectively, by these two agents. The results suggested that both
GM-CSF and EGF are important regulators of trophoblast cell
function.
VEGF and HB-EGF expression in B6Tert-1 cells under CSE
exposure
We examined the response of two other important mitogens in
B6Tert-1 cells upon CSE and/or MG-132 treatment. As shown in
Figure 6, the expression of VEGF and HB-EGF was increased in
B6Tert-1 cells at the mRNA level under CSE exposure and was
further increased when MG-132 was present during the CSE
treatment. However, this up-regulation was not blocked by the
EGFR inhibitor AG-1478. These results showed that the
synergistic up-regulation of VEGF and HB-EGF expression by
CSE and MG-132 was not by way of activating EGFR as was the
case for the GM-CSF expression up-regulation by CSE and MG-
132. The addition of only MG-132 to the B6Tert-1 cells also
increased the expression of VEGF and HB-EGF mRNAs, but not
to the extent observed when both CSE and MG-132 were present
in FD medium.
Discussion
Cigarette smoke contains about 4,000 toxic compounds [28]. It
is difficult to single out which chemical compound is responsible
for the adverse effects on human health since a smoker is not
smoking any single compound. It is the combined actions of all
these damaging compounds modifying the cellular signaling
pathways over time that define the overall impact of cigarette
smoke on the human body. With this consideration, we chose to
use the whole cigarette smoke extract (CSE) for the present study.
The dose of soluble CSE described here is comparable to those in
previously published studies [29,30] and is pharmacologically
Figure 2. Cigarette smoke extract increases GM-CSF expression in B6Tert-1 cells. (A) Bar graph of real-time RT-qPCR data of GM-CSF mRNA
expression in B6Tert-1 cells treated with 10% CSE in growth medium for 2 days. The relative GM-CSF mRNA expression level was determined against
the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA level. Data are mean 6 SEM. The asterisk (*) indicates a statistically significant
difference (p,0.05), when compared with the control (untreated) cells. (B) Bar graph of GM-CSF ELISA data of the secreted GM-CSF in B6Tert-1
conditioned medium. The medium was collected after 2 days of exposure to 10% CSE. The asterisk (*) indicates a statistically significant difference
(p,0.05), when compared with the control (untreated) cells. Data are mean 6 SEM.
doi:10.1371/journal.pone.0043042.g002
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relevant when compared with the plasma nicotine concentrations
of smokers [31,32].
The regulation of GM-CSF expression in human trophoblast
cells under the influence of cigarette smoking has not been well
studied previously. In this report, we demonstrated that CSE
increased GM-CSF expression and this induction effect is
mediated by a cellular signaling pathway involving EGFR
activation and proteasome inhibition. The transcription factor
NF-kB plays important roles in pro-inflammatory cytokine mRNA
expression and GM-CSF is a target gene of this expression
Figure 3. Effects of inhibitors on CSE-induced GM-CSF mRNA expression. (A) Changes of GM-CSF mRNA expression level in B6Tert-1 cells
treated with different agents in FD medium. CSE: 10% cigarette smoke extract; MG-132: proteasome inhibitor at 5 mM; AG-1478: EGFR kinase inhibitor
at 5 mM; U0126: MEK inhibitor at 5 mM. Cells were pre-treated with inhibitor(s) for 30 min, and then with 10% CSE for another 5 h. DMSO was used as
a vehicle control. The asterisk (*) indicates a statistically significant difference (p,0.05) when compared with CSE-treated cells. (B) Western blot
analysis of the phosphorylation state of ERK1/2 in B6Tert-1 cells treated with 10% CSE without or with inhibitors (5 mM each) as indicated for 30 min.
Total ERK1/2 and GAPDH were used as the total protein and loading controls. Lane 1: FD (no treatment); lane 2: 10% CSE; lane 3: 10% CSE/MG-132;
lane 4: 10% CSE/MG-132 and AG-1478; lane 5: MG-132 alone. The image represents one of three independently performed experiments. (C)
Immunofluorescent staining showing the cellular distribution of NF-kB p65 subunit in B6Tert-1 cells under different treatment conditions. a: FD alone;
b: 10% CSE; c: 10% CSE/MG-132; d: MG-132 alone; e: TNF-a: 50 ng/ml; and f: TNF-a/MG-132. ‘‘N’’ indicates the nucleus and the arrow indicates the NF-
kB p65 subunit staining. Magnification: 20610. (D) Western blot analysis of the distribution of NF-kB p65 subunit in B6Tert-1 cells under different
treatment conditions. Cytoplasmic proteins were blotted with antibodies against NF-kB and GAPDH while nuclear proteins were blotted with
antibodies against NF-kB and nucleoporin p62. Lanes 1: FD (no treatment); lanes 2: 10% CSE; lanes 3: 10% CSE/MG-132; and lanes 4: MG-132 alone.
The image represents one of three independently performed experiments.
doi:10.1371/journal.pone.0043042.g003
Cigarette Smoking and GM-CSF in Trophoblast
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regulation [26]. Our results, however, suggested that GM-CSF
mRNA expression can be up-regulated via EGFR activation and
proteasome inhibition in trophoblast B6Tert-1 cells under the
exposure of cigarette smoke by an NF-kB independent mecha-
nism. In the cells treated with CSE under our experimental
conditions (Figure 3C–D), there was no apparent translocation of
the NF-kB p65 subunit from the cytosol to the nucleus, a process
necessary for NF-kB-mediated transcription activation. On the
other hand, in the cells treated with the known NF-kB-activating
cytokine TNF-a, the NF-kB p65 subunit was translocated into the
nucleus, and the translocation could be blocked by the proteasome
inhibitor MG-132; indicating that the B6Tert-1 cells can respond
to cytokine stimulation with a proper NF-kB activation [33]. The
fact that an NF-kB activation-inhibiting proteasome inhibitor
(MG-132) further enhanced the CSE-induced GM-CSF mRNA
expression (Figure 3A) suggests that the CSE-mediated GM-CSF
up-regulation in the trophoblast cells is the consequence of
impaired proteasome function. Similarly, nicotine-induced inhibi-
tion of proteasomal chymotrypsin-like activity was observed in the
mouse brain in animals injected with nicotine [34]. Proteasome
inhibition has recently been shown to increase NF-kB-mediated
transcription instead of inhibiting it in endometrial cancer cells,
with an increase in nuclear NF-kB and NF-kB/target gene
promoter complex formation [35]. But in our study, the CSE-
induced and MG-132-enhanced GM-CSF expression may not be
attributable to NF-kB activation, or retention of NF-kB on the
promoter following activation and translocation as previously
reported [36].
The CSE/MG-132-induced GM-CSF mRNA expression was
prevented by AG-1478, a highly selective inhibitor of the EGFR
kinase (Figure 3A), suggesting that the GM-CSF mRNA expres-
sion up-regulation was regulated via activation of EGFR signaling.
Indeed, treating B6Tert-1 trophoblast cells with EGF resulted in
an increased GM-CSF mRNA expression (Figure 4). Our results
were consistent with the previous findings that EGFR can be
aberrantly activated by cigarette smoke which also impairs EGFR
degradation, leading to downstream ERK1/2 phosphorylation in
human airway epithelial cells [37], and that EGFR activation is
associated with an enhanced expression of GM-CSF in keratino-
cyte [38]. Our data delineate a possible mechanism underlying the
CSE/MG-132-induced GM-CSF up-regulation: that the in-
creased ERK1/2 phosphorylation activates the GM-CSF tran-
scription. Indeed, treating B6Tert-1 cells with U0126, a MEK1/2
inhibitor, inhibited CSE/MG-132-induced GM-CSE up-regula-
tion (Figure 3A). As shown in Figure 3B, the addition of only MG-
132 increased ERK1/2 phosphorylation in the B6Tert-1 cells; a
phenomenon well documented in previous publications [39–41].
The increased ERK1/2 phosphorylation by MG-132 would exert
different functional outputs depending on the cell state dictated by
the presence of other stimuli. In our experiments, CSE in addition
to MG-132 synergistically increased the expression of GM-CSF.
Figure 4. EGF up-regulates GM-CSF mRNA expression in
B6Tert-1 cells. (A) Bar graph of real-time RT-qPCR data of GM-CSF
mRNA expression in B6Tert-1 cells treated with EGF. FD: untreated; EGF:
50 ng/ml; AG-1478: 5 mM. Cells were pre-treated with AG-1478 for
30 min and then with 10% CSE for another 5 h. The asterisk (*) indicates
a statistically significant difference (p,0.05) when compared with the
untreated (FD) cells.
doi:10.1371/journal.pone.0043042.g004
Figure 5. GM-CSF and EGF increase viability and proliferation of B6Tert-1 cells. B6Tert-1 cells were seeded in 96-well plates and treated
with GM-CSF or EGF at different concentrations as indicated in FD medium for 24 h. The data are expressed as the percentage of treated/untreated.
Each data point represents mean 6 SEM (n = 7).
doi:10.1371/journal.pone.0043042.g005
Cigarette Smoking and GM-CSF in Trophoblast
PLOS ONE | www.plosone.org 5 August 2012 | Volume 7 | Issue 8 | e43042
Cigarette smoking during pregnancy is known to increase the
risks of a number of adverse outcomes, such as fetal growth
restriction and preterm birth. Paradoxically, smoking reduces the
risk of preeclampsia. We have shown in this study that cigarette
smoke extract in the culture medium of a trophoblast cell line,
mimicking systemic cigarette smoke exposure, induces GM-CSF
expression. The GM-CSF up-regulation in response to cigarette
smoking may be a compensatory mechanism for repairing the
pathological damages induced by cigarette smoking in the
trophoblast based-placental structures, working in favor of
sustaining the pregnancy. As presented in Figure 5, treating
B6Tert-1 cells with exogenous GM-CSF increased trophoblast cell
viability and proliferation. Our results corroborated previous
reports that GM-CSF and its receptors expressed by trophoblast
cells provide onsite actions of regulating trophoblast cell prolifer-
ation, invasion and differentiation [42]. The increased expression
of GM-CSF upon CSE treatment in B6Tert-1 cells may explain, in
part, that low doses of CSE increased the cell viability and
proliferation (Figure 1). In addition, CSE and/or MG-132
treatment increased other growth promoting factors in B6Tert-1
cells, i.e., VEGF or HB-EGF, but via different mechanisms.
Although smoking is associated with a reduced incidence of
preeclampsia, the net effect of smoking in regard to pregnancy
outcomes is undoubtedly unfavorable. But the important lesson
from this study is that we have identified the cytokine GM-CSF as
being a possible mediator of such a dubious benefit of maternal
cigarette smoking. The most significant and novel finding of this
study is that the combination of CSE exposure and proteasome
Figure 6. Effects of CSE and proteasome inhibition on VEGF and HB-EGF mRNA expression. Cells were pre-treated with inhibitor(s) for
30 min, and then with 10% CSE for another 5 h. DMSO was used as a vehicle control. A: VEGF mRNA expression levels in B6Tert-1 cells treated with
different agents in FD medium. B: HB-EGF mRNA expression levels in B6Tert-1 cells treated with different agents in FD medium. CSE: 10% cigarette
smoke extract; MG-132: proteasome inhibitor at 5 mM; AG-1478: EGFR kinase inhibitor at 5 mM. The asterisk (*) indicates a statistically significant
difference (p,0.05) when compared with CSE-treated cells.
doi:10.1371/journal.pone.0043042.g006
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inhibition increased extracellular signal-regulated kinases (ERK1/
2) phosphorylation, via activating the EGFR, to serve as a possible
mechanism underlying the CSE/proteasome inhibition-induced
GM-CSF up-regulation. The up-regulated expression of GM-CSF
in the trophoblasts after cigarette smoke exposure could play an
important role in maintaining trophoblast integrity to increase the
survival of cells (Figure 7). Previous studies have demonstrated that
proteasome activity is impaired in placenta in women with
preeclampsia [43,44]. Our finding in this study will allow us to
dissect the molecular and cellular events associated with the
reduced-risk of preeclampsia in smokers, and take full advantage
of the benefits endowed by GM-CSF to pregnant women highly
prone to preeclampsia, without having to derive these benefits
from cigarette smoking.
Materials and Methods
Materials
All tissue culture reagents, cytokines GM-CSF and TNF-a, and
the Trizol reagent were purchased from Invitrogen (Carlsbad, CA,
USA) unless specified otherwise. Inhibitors MG-132, AG-1478
and U0126 were purchased from CalBiochem (San Diego, CA,
USA). Other chemicals were purchased from Sigma-Aldrich (St.
Louis, MO, USA).
Cell culture
An immortalized normal human cytotrophoblast cell line,
B6Tert-1, was established, characterized, and cultured as
described previously [45]. All cell culture dishes were pre-coated
with 75 mg/ml Cellmatrix Type I-A (Institute of Biochemistry,
Osaka, Japan). The B6Tert-1 cells were cultured in F12/DMEM
(1:1) medium (FD) supplemented with 10 ng/ml EGF, 2 mM
glutamine, 10 mg/ml insulin and 0.1%BSA; in a humidified
incubator at 37uC with 5% CO2 and 95% air.
Cigarette smoke extract preparation
Research-reference cigarettes were obtained from the Kentucky
Tobacco Research and Development Center, University of
Kentucky (Lexington, KY, USA). Cigarette smoke extract (CSE)
was prepared as described previously with modifications [46–48].
Smoke from one research-grade filter-less cigarette, 1R3F
containing 15 mg tar and 1.16 mg nicotine, was bubbled through
25 ml of FD medium via a 10-ml glass syringe at a rate of 5 min
per cigarette. The CSE stock (considered as 100%) was filtered
through a 0.22-mm filter and stored at 280uC. The CSE was
diluted in FD medium immediately prior to use.
Treatment of cells
Cells were seeded in 12-well culture plates at a density of 36105
cells per well and grown overnight. Inhibitors MG-132, AG-1478,
or U0126 were added, when appropriate, in FD medium 30 min
prior to CSE treatments. CSE was added to the cell culture at a
final concentration of 10% in FD medium with the added
inhibitor(s), and was incubated with cells for 5–6 hours. At the end
of the treatment, cells were either lysed with the Trizol reagent for
total cellular RNA isolation, or lysed with the RIPA buffer for total
cellular protein extraction.
Cell viability and proliferation assays
Cells were seeded into a 96-well plate at a density of 16104/well
and cultured overnight. Cells were then treated with CSE at
different concentrations (0%, 1%, 5%, 10%, 20%, 30%, 40%, and
50%) in a volume of 100 ml/well for 24 h in FD medium. EGF or
GM-CSF was added, when appropriate, at different final
concentrations. Cell viability was evaluated using the CellTiter-
BlueH Cell Viability Assay Kit (Promega, Madison, WI, USA).
Cell proliferation was evaluated using the CyQUANTH NF Cell
Proliferation Assay Kit (Invitrogen).
RNA isolation and real-time RT-qPCR
Total cellular RNA was isolated using the Trizol reagent
according to the manufacturer’s protocol. Reverse transcription of
each sample was carried out using the iScript cDNA Synthesis Kit
(Bio-Rad, Hercules, CA). Real-time qPCR was carried out on a
Bio-Rad MyiQ system using the iQ SYBR Green Supermix
reagents (Bio-Rad). The PCR program and methods of quanti-
fication were described previously [49]. PCR primers were
designed with the aid of the Beacon Designer 7.0 software
(PREMIER BioSoft International, Palo Alto, CA) and synthesized
by Integrated DNA Technologies (Coralville, IA, USA). The
primer sequences for human glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) and GM-CSF were described previously
[49]. The primer sequences for HB-EGF are 59- AAT CGC TTA
TAT ACC TAT GAC-39 (forward) and 59- TAA CCT CCT
CTC CTA TGG-39 (reverse); those for VEGF are 59- TTG CTG
CTC TAC CTC CAC-39 (forward) and 59- CAC AAG ATG
GCT TGA AGA TG-39 (reverse). The relative mRNA expression
of target genes in each RNA sample was calculated as copy
numbers per GAPDH mRNA copy.
Enzyme-linked immunosorbent assay (ELISA)
Cells were seeded in 12-well culture plates at a density of 16105
cells per well and grown overnight, and then treated with 10%
CSE in fresh culture medium for another 48 h. The GM-CSF
protein secreted in the culture medium was quantified using a
QuantikineTM human GM-CSF immunoassay kit (R&D Systems,
Minneapolis, MN, USA) as described previously [49]. The
quantities of GM-CSF were expressed as pg/ml after normalizing
with the cell number in the culture dishes.
Immunofluorescent staining
Cells were seeded on 12-mm diameter glass coverslips (Thermo
Fisher Scientific, Waltham, MA, USA) at 56104 cells per
Figure 7. Cigarette smoke activates different signaling path-
ways regulating trophoblast cell viability and proliferation via
GM-CSF expression.
doi:10.1371/journal.pone.0043042.g007
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coverslip, grown overnight, and then treated with different agents
in FD medium. After the treatments, cells were washed with cold
PBS and fixed with 4% para-formaldehyde at 4uC for 15 min and
then with cold acetone:alcohol (1:1) for another 10 min. The cells
were washed with PBS and then blocked with 1% BSA in PBS
containing 0.1% Triton X-100 for 30 min. The cells were then
incubated with the primary antibody against NF-kB p65 subunit
at 1:100 dilution (Santa Cruz Biotechnology, Santa Cruz, CA) in
the blocking buffer for 1 h at the room temperature. A goat anti-
mouse IgG conjugated with Cy2 in the blocking buffer was applied
to the cells at 1:200 dilution and incubated for 1 h (Jackson
ImmunoResearch laboratories, Pennsylvania, PA, USA) following
the primary antibody incubation and washing in PBS. After a final
wash with PBS, the cells were mounted with Biomeda Gel/
MountTM (Thermo Fisher Scientific), viewed and photographed
under a Nikon, Eclipse TE2000E microscope equipped with the
NIS-Element Advanced Research software.
Nuclear Protein Extraction
Cytoplasmic and nuclear proteins were extracted using a
Nuclear Extract Kit (Active Motif, Carlsbad, CA) according to
the manufacturer’s instructions. Briefly, cells were seeded in 60-
mm tissue culture dishes (Corning Incorporated, Corning, NY) at
26106 cells per dish, grown overnight, and then treated with the
different agents in FD medium. Extracted proteins were quantified
using a DC Protein Assay Kit (Bio-Rad) and subjected to
electrophoresis followed by western blot analysis as described
below.
Western Blot Analysis
The procedures to evaluate protein expression changes in the
B6Tert-1 cells treated with the different agents were carried out as
described previously [50]. Briefly, cells were washed with PBS and
lysed in RIPA buffer at 4uC for 30 min (RIPA with inhibitors:
20 mM Tris-HCl at pH 8.0, containing 150 mM NaCl, 1% NP-
40, 0.5% sodium deoxycholate, and 0.1%SDS; and enzyme
inhibitors: 1 mM PMSF, 2 mg/ml aprotinin, 2 mg/ml leupeptin,
2 mg/ml antipain, 50 mg/ml soybean trypsin inhibitor, 10 mM
NaF, 1 mM Na3VO4). The supernatant was collected after
centrifugation of the lysate at 10,0006 g for 10 min. The protein
concentrations were determined using a DC Protein Assay Kit.
Forty-micrograms of the total protein from each sample were
resolved on a 10% gel by SDS-PAGE and electro-transferred to a
nitrocellulose membrane. The membranes were blocked with 5%
non-fat milk in TBS-T (20 mM Tris-HCl at pH 7.4, containing
150 mM NaCl, 0.1% Tween-20), and incubated with the
appropriate primary antibodies. The antibodies used were
GAPDH (used at 1:5,000 dilution), total ERK1/2 (1:5,000), and
NF-kB (1:1,000) (Santa Cruz Biotechnology); phosphorylated
ERK1/2 (1:1,000; Cell Signaling Technology, Inc., Danvers,
MA); and nucleoporin p62 (1:2,000; Pharmingen, San Diego, CA).
After incubation with the primary antibodies, the membranes were
washed and incubated for 1 h with the appropriate secondary
antibodies conjugated with the horseradish peroxidase (HRP)
(1:10,000, Promega). The membranes were then washed and
subjected to enhanced-chemiluminescence reaction (ECL, Pierce
Biotechnology, Inc., Rockford, IL, USA) before exposure to X-ray
films.
Statistical analysis
All experiments were performed at least three times. All data are
expressed as means 6 SEM. All data were analyzed using
Student’s t-Test. Differences were considered statistically signifi-
cant, if p,0.05.
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